Delivery Order SPE2DX22D0010-SPE2D824FPR89

Award Date 8/5/24
Potential Completion Date 8/6/24
Potential Value $13K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This $6,718.16 firm fixed-price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office division. The contract is for the supply of NUCYNTA (tapentadol) 50mg tablets, a prescription pain medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at up to $999,999,999 through December 2025, for providing a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded this $11,978.68 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corporation for the supply of NUCYNTA ER (tapentadol extended-release) 100mg tablets. This delivery order is part of a larger indefinite-delivery contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to efficiently procure a comprehensive range of medical commodities to...
This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of NUCYNTA ER (Tapentadol Extended-Release) 50 mg tablets. The contract has a ceiling value of $1,853.24 and a period of performance through September 16, 2024. The contract is not set aside for any particular business category. AmerisourceBergen holds a larger Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency responsible for supplying medical commodities. The prime contractor is Amerisourcebergen Drug Corporation, a large pharmaceutical distributor. The contract is for the delivery of 4,565,214,063 NUCYNTA (tapentadol) 50mg tablets, a prescription pain medication. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,993.17 and a completion date of July 22,...
This is a federal contract award by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NUCYNTA ER (Tapentadol) 200mg tablets, a prescription pain medication. The contract has a ceiling value of $12,810.09 and will run through August 23, 2024. This award is not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order valued at $1,155.92 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of NUCYNTA 50 MG TABLET 100S. The delivery order is part of an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,930.51 firm fixed-price contract is for the supply of NUCYNTA (tapentadol) 100mg tablets, a pain medication. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is a for-profit organization registered in the System for Award Management...
This is a $1,330.66 delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation. The contract is for the supply of NUCYNTA 50 MG TABLET 100S, a pharmaceutical product. This delivery order falls under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of NUCYNTA ER (Tapentadol Extended-Release) 100mg tablets, a prescription medication. The contract is a single-award Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to provide a...
This is a firm-fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,502.56 contract is for the supply of NUCYNTA ER 50 MG TABLET 60S, a prescription pain medication. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which provides a range of pharmaceutical products and medical supplies to support military...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D824FPR89
    Delivery Order

This firm-fixed-price delivery order contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $12,635.41, is for the delivery of NUCYNTA (tapentadol) 50mg tablets, a prescription pain medication. This delivery order falls under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued up to $999,999,999, for the supply of a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and is expected to be completed by August 6, 2024.

Generated 11/4/24, 11:32 AM